kampirone has been researched along with Postoperative Nausea and Vomiting in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apfel, CC; Chassard, D; Diemunsch, P; Eberhart, L; Fox, GM; Gan, TJ; Kranke, P; Lebuffe, G; Minkowitz, HS; Röhm, KD; Tramèr, MR; Wallenborn, J | 1 |
1 trial(s) available for kampirone and Postoperative Nausea and Vomiting
Article | Year |
---|---|
Intravenous buspirone for the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antiemetics; Buspirone; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Postoperative Nausea and Vomiting; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Dopamine D3; Serotonin 5-HT1 Receptor Agonists; Young Adult | 2012 |